Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of BRV-TV Rotavirus Vaccine in Healthy Indian Infants
NCT00757926Phase 2Withdrawn
- Sponsor
- Shantha Biotechnics
- Start
- Sep 2009
- Primary completion
- Aug 2010
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rotavirus infection comparing BRV-TV with Placebo (2 arms). Primary endpoint: Safety and tolerability. Planned start Sep 2009; status: withdrawn.
02
Drugs
BRV-TV
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00757926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00757926.